Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ECYT
Delisted

Endocyte Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Jan 18, 2019

Range Low Price High Price Comment
30 days $23.97 $24.00 Friday, 18th Jan 2019 ECYT stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $23.37 $24.00
52 weeks $2.81 $24.00

Historical Endocyte prices

Date Open High Low Close Volume
Aug 24, 2018 $18.05 $18.46 $17.53 $18.37 1 616 780
Aug 23, 2018 $17.67 $18.25 $17.45 $18.00 1 100 098
Aug 22, 2018 $17.59 $18.05 $17.25 $17.70 624 099
Aug 21, 2018 $17.95 $18.09 $17.59 $17.63 623 475
Aug 20, 2018 $18.09 $18.40 $17.52 $17.95 746 065
Aug 17, 2018 $17.10 $18.10 $17.10 $17.94 969 430
Aug 16, 2018 $16.50 $17.38 $16.25 $17.06 777 664
Aug 15, 2018 $16.29 $16.54 $16.00 $16.49 458 078
Aug 14, 2018 $15.94 $16.57 $15.68 $16.35 746 354
Aug 13, 2018 $15.93 $16.25 $15.63 $15.80 509 987
Aug 10, 2018 $16.10 $16.60 $15.80 $15.93 756 524
Aug 09, 2018 $16.02 $16.48 $16.00 $16.29 385 104
Aug 08, 2018 $16.09 $16.22 $15.83 $16.02 382 126
Aug 07, 2018 $16.06 $16.29 $15.96 $16.05 406 441
Aug 06, 2018 $15.38 $16.56 $15.30 $15.88 664 121
Aug 03, 2018 $16.24 $16.36 $15.26 $15.42 619 130
Aug 02, 2018 $16.23 $16.72 $16.02 $16.30 710 070
Aug 01, 2018 $15.25 $16.49 $15.22 $16.28 1 065 910
Jul 31, 2018 $15.35 $15.40 $13.75 $15.32 1 393 964
Jul 30, 2018 $15.16 $15.51 $14.78 $15.31 790 864
Jul 27, 2018 $15.38 $15.51 $14.65 $15.20 704 702
Jul 26, 2018 $15.32 $15.68 $15.01 $15.54 598 379
Jul 25, 2018 $15.65 $16.11 $15.14 $15.27 783 453
Jul 24, 2018 $16.75 $16.91 $15.41 $15.51 1 344 200
Jul 23, 2018 $17.26 $17.47 $16.57 $16.72 1 048 850
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT